• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CODMAN & SHURTLEFF CODMAN 3000; HEPARTIC ARTERY INFUSION PUMP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CODMAN & SHURTLEFF CODMAN 3000; HEPARTIC ARTERY INFUSION PUMP Back to Search Results
Model Number AP03000H
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Pseudoaneurysm (2605); Gastrointestinal Hemorrhage (4476)
Date of Event 12/01/2018
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
This event occured in 2018, and the device was explanted in 2019 after course of treatment was completed.Intera did not acquire the product line and reporting responsibilities until 2020, but is making this report based on what was found in the literature.Intera oncology reached out to one of the abstract authors to obtain more information to file this report.The physician stated the device did not appear damaged.Intera was able to determine the serial number based off of the device tracking information and reviewed the device history record (dhr).The dhr for this serial number was reviewed and no nonconformities were noted in the manufacture.Known adverse events listed in the codman ifu include: catheter thrombosis, bolus path occlusion, vessel thrombosis, pump dislodgement, seroma or recurrent hematoma, infection, extravasation, catheter shear, dislodgement or leakage, and migration.There is no currently indication of an increased trend of this adverse event.
 
Event or Problem Description
This report is being made upon identifying an abstract in the 2020 acg annual meeting abstracts, october 2020 volume 115, published online 02 november 2020.Abstract titled: hemobilia due to arteriobiliary fistula from a hepatic artery infusion pump pseudoaneurysm.The abstract included details of a possible adverse event involving hepatic artery infusion therapy that may be device-related.Specifically according to the abstract: ct demonstrated a 36 mm hypoattenuating collection at the tip of the hepatic artery pump causing biliary duct compression and upstream dilation.Ercp (endoscopic retrograde cholangiopancreatography) was performed which demonstrated a moderate biliary stricture at the level of the haip tip and a plastic biliary stent was placed.Patient re-presented 3 weeks later with increased abdominal pain, melena, and jaundice.Ct angiogram (cta) demonstrated a 26 mm thrombosed pseudoaneurysm in the gda at the tip of the haip without active bleeding.Repeat ercp showed hemobilia and clots with a 20 mm cavity seen in the middle third of the bile duct.A covered metal stent was placed across this area.Patient presented 10 days later with recurrent symptoms and underwent cta that showed hyperattenuating material in the common bile duct with biliary dilation.Arteriogram was negative for active extravasation or pseudoaneurysm, with the gda not opacified.Ercp was repeated which revealed an occluded biliary stent with blood products.Balloon sweeps were performed which lead to migration of the proximal end of the stent to the level of the known pseudoaneurysm and active bleeding was noted.A new covered metal stent was placed and bleeding subsided.Repeat arteriogram showed active bleeding from the gastroduodenal artery stump into a 20 mm collection between the biliary stent and the haip tip, which was treated with hepatic artery stent grafting.Patient later had device explanted as course of treatment was completed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CODMAN 3000
Common Device Name
HEPARTIC ARTERY INFUSION PUMP
Manufacturer (Section D)
CODMAN & SHURTLEFF
325 paramount drive
rayhnam MA 02767
MDR Report Key10929604
Report Number3015537318-2020-00014
Device Sequence Number2631633
Product Code LKK
UDI-Device Identifier10886704043591
UDI-Public10886704043591
Combination Product (Y/N)Y
Initial Reporter StateMO
Initial Reporter CountryUS
PMA/510(K) Number
P890055
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2016
Device Explanted Year2019
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source health professional,literatur
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 12/01/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberAP03000H
Device Catalogue NumberAP03000H
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/02/2020
Initial Report FDA Received Date12/01/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient Age38 YR
Patient Weight87
-
-